Literature DB >> 12868789

Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume.

C R Daane1, H D Golab, J H J Meeder, M J Wijers, A J J C Bogers.   

Abstract

The aim of this prospective randomized study was to compare the effects of the transfusion of unprocessed and cell saver-processed residual cardiopulmonary bypass (CPB) volume on haemostasis, complement activation, postoperative blood loss and transfusion requirements after elective cardiac surgery. Blood samples were taken at eight points in time, perioperatively. Haematological data, including haemoglobin, haematocrit and platelet counts as well as coagulation parameters, including activated partial thromboplastin time, prothrombin time, thrombin time, fibrinogen and the fibrinolytic parameter D-dimers, were measured from each blood sample. For the assessment of complement activation, the total complement CH50 was analysed. In addition, postoperative blood loss and transfusion requirements were measured during the first 24 hours, postoperatively. The results of the study showed impaired haemostasis after the transfusion of both unprocessed and processed CPB volume. No significant differences were found between the groups in the measured coagulation parameters. Nor was a significant difference found in the complement concentration. However, in patients transfused with unprocessed CPB volume, a significantly (p = 0.019) higher amount of blood loss was found, postoperatively. In the same group of patients, the number of units of allogeneic erythrocyte concentrate suspension transfused was also significantly (p = 0.023) higher during the first 24 hours, postoperatively, compared to the patients transfused with processed CPB blood. The number of units of fresh frozen plasma and platelet suspension transfused was not significantly different between the groups. In conclusion, processing CPB volume in combination with processing peroperative blood loss may result in reducing the volume of transfusion needed of allogeneic blood products.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868789     DOI: 10.1191/0267659103pf647oa

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  6 in total

1.  Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.

Authors:  Alice Wiefferink; Patrick W Weerwind; Waander van Heerde; Steven Teerenstra; Luc Noyez; Ben E de Pauw; René M H J Brouwer
Journal:  J Extra Corpor Technol       Date:  2007-06

2.  Effects of circuit residual volume salvage reinfusion on the postoperative clinical outcome for pediatric patients undergoing cardiac surgery.

Authors:  Lifen Ye; Ru Lin; Yong Fan; Lijun Yang; Jianling Hu; Qiang Shu
Journal:  Pediatr Cardiol       Date:  2012-12-13       Impact factor: 1.655

3.  Perfusionist strategies for blood conservation in pediatric cardiac surgery.

Authors:  Yves Durandy
Journal:  World J Cardiol       Date:  2010-02-26

4.  The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass.

Authors:  Andrea Colli; Sara Balduzzi; Xavier Ruyra
Journal:  J Cardiothorac Surg       Date:  2012-06-14       Impact factor: 1.637

Review 5.  Blood transfusion practices in cardiac anaesthesia.

Authors:  Hanumantha Rao Mangu; Aloka Samantaray; Muralidhar Anakapalli
Journal:  Indian J Anaesth       Date:  2014-09

6.  The effects on coagulation of the reinfusion of unprocessed residual blood from the cardiopulmonary bypass.

Authors:  Yolande-Leigh Iyer; Philip Hayward; Larry McNicol; Laurence Weinberg
Journal:  BMC Res Notes       Date:  2016-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.